机器人辅助立体定向活检在377例幕上弥漫性胶质瘤成人患者中的诊断率、安全性与术后结局
该回顾性观察研究分析了2006至2016年间单中心连续377例不可切除新诊断幕上弥漫性胶质瘤成人患者的MRI引导机器人辅助立体定向活检,平均每例获取4.2±1.9个样本、2.6±1.2个活检部位,组织病理诊断率98.7%,术后新发神经功能缺损7.7%,术后1个月死亡率2.9%,多部位采样不增加术后并发症。
要点
- 机器人辅助立体定向活检对幕上弥漫性胶质瘤诊断率高达98.7%。
- 术后新发神经功能缺损发生率7.7%,与术前神经功能缺损、活检部位出血≥20 mm及术后影像占位效应增加相关。
- 多活检部位和多样本不增加术后并发症。
核心结论
- 机器人辅助立体定向活检采样诊断准确率高、并发症率低,多部位多样本不增加术后并发症。
研究设计与样本
- 单中心回顾性观察分析2006-2016年连续成人幕上弥漫性胶质瘤的MRI引导机器人辅助立体定向活检,共377例。
主要发现
- 平均每例获取4.2±1.9个活检样本,涉及2.6±1.2个活检部位,组织病理诊断率98.7%。
- 术后新发神经功能缺损发生率7.7%,其预测因素包括术前神经功能缺损(P=0.030)、活检部位出血≥20 mm(P=0.004)和术后影像占位效应增加(P=0.014)。
- 术后Karnofsky功能状态评分下降≥20分发生率为4.0%,预测因素为术后神经功能缺损(P<0.001)和术后影像占位效应增加(P=0.014)。
- 术后影像占位效应增加发生率为4.4%,预测因素为术前颅内压增高(P=0.048)和强化区体积≥13 cm³(P=0.048)。
- 术后1个月死亡率为2.9%,预测因素为术前Karnofsky功能状态评分<70(P=0.045)和术后影像占位效应增加(P<0.001)。
临床怎么用
- 对于不可切除的幕上弥漫性胶质瘤,机器人辅助立体定向活检是一种诊断率高且并发症可接受的组织取样方式。
- 术前存在神经功能缺损、活检部位出血≥20 mm或术后影像占位效应增加的患者术后新发神经功能缺损风险较高,应加强监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Multiple biopsy samples are warranted for the histomolecular diagnosis of diffuse gliomas in the current molecular era, which possibly increases morbidity. OBJECTIVE: We assessed diagnostic yield, safety, and risk factors of postoperative morbidity after robot-assisted serial stereotactic biopsy sampling along 1 biopsy trajectory for diffuse gliomas. METHODS: Observational retrospective analysis of consecutive magnetic resonance imaging-based robot-assisted stereotactic biopsies performed at a single institution to assess the diagnosis of nonresectable newly diagnosed supratentorial diffuse gliomas in adults (2006-2016). RESULTS: In 377 patients, 4.2 ± 1.9 biopsy samples were obtained at 2.6 ± 1.2 biopsy sites. The histopathologic diagnosis was obtained in 98.7% of cases. Preoperative neurologic deficit (P = 0.030), biopsy site hemorrhage ≥20 mm (P = 0.004), and increased mass effect on postoperative imaging (P = 0.014) were predictors of a new postoperative neurologic deficit (7.7%). Postoperative neurologic deficit (P < 0.001) and increased mass effect on postoperative imaging (P = 0.014) were predictors of a Karnofsky Performance Status decrease ≥20 points postoperatively (4.0%). Increased intracranial pressure preoperatively (P = 0.048) and volume of the contrast-enhanced area ≥13 cm3 (P = 0.048) were predictors of an increased mass effect on postoperative imaging (4.4%). Preoperative Karnofsky Performance Status <70 (P = 0.045) and increased mass effect on postoperative imaging (P < 0.001) were predictors of mortality 1 month postoperatively (2.9%). Preoperative neurologic deficit (P = 0.005), preoperative Karnofsky Performance Status <70 (P < 0.001), subventricular zone contact (P = 0.004), contrast enhancement (P = 0.018), and steroid use (P = 0.003), were predictors of the inability to discharge to home postoperatively (37.0%). CONCLUSIONS: Robot-assisted stereotactic biopsy sampling results in high diagnostic accuracy with low complication rates. Multiple biopsy sites and samples do not increase postoperative complications.
引用
- Zanello M, Roux A, Senova S, et al. Robot-Assisted Stereotactic Biopsies in 377 Consecutive Adult Patients with Supratentorial Diffuse Gliomas: Diagnostic Yield, Safety, and Postoperative Outcomes. World Neurosurg. 2021. PMID: 33412330. doi:10.1016/j.wneu.2020.12.127
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。